02169nas a2200397 4500000000100000008004100001260001300042653000900055653002200064653001500086653001100101653000900112653001800121653001100139653001200150653003100162653000900193653001600202653001800218653003900236653002600275653001700301100001100318700001100329700001500340700001300355700001600368700001300384700001300397245008500410856004100495300001100536490000700547520120300554022001401757 2002 d c2002 Jun10aAged10aAged, 80 and over10aCellulitis10aFemale10aFoot10aFoot Diseases10aHumans10aleprosy10aMagnetic Resonance Imaging10aMale10aMiddle Aged10aOsteomyelitis10aPeripheral Nervous System Diseases10aRetrospective Studies10aTarsal Bones1 aMaas M1 aSlim E1 aHeoksma AF1 aKleij AJ1 aAkkerman EM1 aHeeten G1 aFaber WR00aMR imaging of neuropathic feet in leprosy patients with suspected osteomyelitis. uhttp://ila.ilsl.br/pdfs/v70n2a01.pdf a97-1030 v703 a
This study was undertaken to analyze MRI findings in leprosy patients with neuropathic feet, which are suspected of having osteomyelitis. As far as we know, there is no literature concerning osteomyelitis and MRI in neuropathic leprosy feet at present. Therefore, we have included MRI examination of 18 events of suspected osteomyelitis in 12 leprosy patients. All patients with long-standing neuropathic foot problems were clinically suspected of having osteomyelitis. All patients underwent the MRI protocol with the inclusion of Two Point Dixon Chemical Shift Imaging as a fat-suppression sequence. For the MRI evaluation, we used signs that are described in literature for detecting osteomyelitis in diabetic feet. The primary MRI signs were positive in 17 of 18 patients. The secondary MRI signs were positive in 100% of the patients. Our results show that MRI with the use of Two Point Dixon Chemical Shift Imaging is a promising diagnostic modality to detect osteomyelitis in the presence of neurosteoarthropathic changes in patients with leprosy. Whenever available, MRI could play an important role in detecting osteomyelitis in leprosy patients with long-standing neuropathic feet.
a0148-916X